Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 27%
Buy 9%
Hold 55%
Sell 9%
Strong Sell 0%

Bulls say

Universal Health Services is poised for future growth as it continues to expand its behavioral health center offerings in key markets like Nevada, Texas, and California. Despite some core growth challenges in the first quarter of 2026, management remains confident in achieving its full-year guidance and the long-term potential of the company. With a diversified revenue mix and a focus on environmental sustainability, UHS is well-positioned for success in the healthcare industry.

Bears say

Universal Health Services is facing multiple risks, including potential impacts to Medicaid funding and reimbursement, potential volume deceleration, possible cost trends, regulatory and media scrutiny, and margin pressures. These risks, along with the company's exposure to a limited number of states and potential labor shortages, could hinder its ability to generate strong top-line growth and margins, impacting investor sentiment and potentially limiting its ability to deploy capital effectively. As a result, the negative outlook is driven by the need for careful execution in the face of multiple headwinds, and a potential downside scenario analysis yields a share price of approximately $132.

UHS has been analyzed by 11 analysts, with a consensus rating of Hold. 27% of analysts recommend a Strong Buy, 9% recommend Buy, 55% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 11 analysts, UHS has a Hold consensus rating as of Jun 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $212.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $212.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.